NASHUA, N.H., July 10 /PRNewswire-FirstCall/ -- iCAD, Inc. , an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early detection of cancer, today announced that the Company has achieved record-high customer satisfaction ratings in the Mammography CAD market, according to the independent healthcare research group MD Buyline.
In MD Buyline’s User Satisfaction Report for the first two quarters of 2008, iCAD remains #1 in mammography CAD for user satisfaction in system performance, system reliability, installation/implementation, applications training, service response time and service repair quality compared to Hologic/R2. Additionally, iCAD has attained record-high customer service ratings in the categories of System Reliability, Service Repair Quality and overall service and quality.
“We are pleased to see that according to these results, we have been able to maintain the industry’s best customer satisfaction ratings this year,” said Ken Ferry, President and CEO of iCAD, Inc. “It is even more exciting for iCAD to have achieved its all time high rankings for several of the categories in the report. iCAD is dedicated to delivering superior CAD solutions and customer service that enable radiologists to detect the hardest to find cancers earlier. We thank iCAD users for these high rankings and will continue our mission of providing our customers with first class service and support.”
About MD Buyline
MD Buyline provides the most comprehensive database of information on healthcare products. Their data assists healthcare providers through every phase of the purchasing process from researching Emerging Technologies to final negotiations. MD Buyline members use the data to make informed decisions, which enables cost savings and operational efficiencies. For MDBuyline, contact Rod Faulkner, analyst at 214-891-6796 or via e-mail at rod.faulkner @mdbuyline.com
About iCAD, Inc.
iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by more than 2,200 women’s healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.
For iCAD, contact Darlene Deptula-Hicks at 603-882-5200 x7944, or via email at
For Public Relations, contact Jill Testagrossa of Schwartz Communications at
781-684-0770 or via e-mail at icad@schwartz-pr.com
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995:
Certain statements contained in this News Release constitute “forward- looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company’s filings with the Securities and Exchange Commission. The words “believe,” “demonstrate,” “intend,” “expect,” “estimate,” “anticipate,” “likely,” and similar expressions identify forward- looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.
CONTACT: Darlene Deptula-Hicks of iCAD, +1-603-882-5200, ext. 7944,
ddeptula@icadmed.com; Investor Relations, Anne Marie Fields of
Lippert-Heilshorn & Associates, +1-212-838-3777, ext. 6604, icad@lhai.com;
or Public Relations, Jill Testagrossa of Schwartz Communications,
+1-781-684-0770, icad@schwartz-pr.com
Web site: http://www.icadmed.com/
